Home » News & Announcements » ようこそ、藤原一夫先生

ようこそ、藤原一夫先生

Posted by: The Sumaira Foundation in News & Announcements

November 1, 2023 — The Sumaira Foundation is pleased to welcome Prof. Kazuo Fujihara of Fukushima Medical University School of Medicine in Japan to join TSF’s international Medical Advisory Board. He joins TSF as the first NMOSD/MOGAD expert from Japan.

Prof. Kazuo Fujihara

Kazuo Fujihara is a Professor at the Department of Multiple Sclerosis Therapeutics at Fukushima Medical University School of Medicine and the director of the Multiple Sclerosis & Neuromyelitis Optica Center at Southern TOHOKU Research Institute for Neuroscience (STRINS) in Koriyama, Japan.

Prof. Fujihara is a neurologist and has mainly worked in the field of multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), MOG antibody-associated disease (MOGAD) and related neuroimmunological disorders.

He is a member of:

• the International Panel on Diagnosis of MS (the 2010, 2017 and 2023~2024 revisions to the McDonald Criteria)
• the International Panel on NMO Diagnosis (the 2015 and 2025 International Consensus Diagnostic Criteria of NMOSD)
• the International Panel on Diagnosis of MOGAD (2020~2023)
• the International Multiple Sclerosis Differential Diagnosis Consortium of Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) [Co-chair of the Working Group on MS Differential Diagnosis in Global Populations] (2021~2023)
• the International Advisory Committee on Clinical Trials in MS (2022~2025)

Since 2013, he has served on the Executive Committee of the International Medical and Scientific Board of The Multiple Sclerosis International Federation (MSIF) and and the Board of European Charcot Foundation (ECF). He is an inaugural member and President (2018~) of Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS), and Immediate Past President (2019~2022) of the Japanese Society for Neuroimmunology (JSNI).